The Division of Atherosclerosis and Vascular Medicine is committed to reducing pain, suffering, and death from cardiovascular disease through coordinated research, patient care, and education activities.
- Performing innovative basic, clinical, and translational research
- Providing state-of-the-art healthcare reflecting evidence-based guidelines and informed by current research
- Training the next generation of lipidologists, preventive cardiologists, and researchers
Strategies include developing in vitro and animal models that emulate key aspects of human metabolism, using these models to test hypotheses about molecular mechanisms for lipid disorders, obesity, diabetes, and atherosclerosis, and, ultimately, translating these insights into improvements in diagnosis, prevention, and treatment of vascular disease in humans by: